在心肺旁路术期间对肝素耐药性的贡献因素
Tomoaki Yamashiro1, Yoshiyuki Takami2, Yasushi Takagi3
1Department of Clinical Engineering, Fujita Health University Hospital, 1-98 Dengakugakubo, Kutsukake, Toyoake, Aichi, 470-1192, Japan. tyama@fujita-hu.ac.jp.
概括
在心肺绕道 (CPB) 期间的肝素耐药性 (HR) 由低的手术前白蛋白和高纤维素素水平预测. 识别这些因素可以帮助管理HR并改善患者的治疗结果.
科学领域:
- 心血管外科心血管外科
- 麻醉学 麻醉学
- 血液学 血液学 血液学
背景情况:
- 肝素耐药性 (HR) 复杂化了心肺绕道 (CPB) 程序.
- 在初始未分离肝素 (UFH) 剂量后HR的风险因素需要进一步澄清.
研究的目的:
- 在CPB之前,在初始UFH剂量为500 IU/kg后,研究HR的促成因素.
- 在接受CPB的患者中确定HR的预测生物标志物.
主要方法:
- 对371名接受CPB治疗的患者进行回顾性分析,用500 IU/kg的UFH剂量.
- HR的定义是未能达到激活凝血时间 (ACT) > 480秒.
- 多变量后勤回归和ROC曲线分析以确定预测因素.
主要成果:
- HR发生在9.7%的患者中.
- 手术前低白蛋白 (<3.8 g/dL) 和高纤维素素 (>303 mg/dL) 是HR的独立预测因素.
- 专和纤维素素显示出良好的预测性表现 (AUC分别为0.78和0.77).
结论:
- 手术前的白蛋白和纤维素水平是CPB期间HR的显著预测因素.
- 针对性监测和低白蛋白或高纤维素素患者的潜在干预措施可以减轻HR风险.
- 这些发现有助于优化CPB期间的肝素管理.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
697
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
697
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Disorders of Hemostasis
906
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
906
Vascular Resistance
3.9K
Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
3.9K
Extrinsic and Intrinsic Pathways of Hemostasis
7.6K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
7.6K


